Biogen Inc.
BIIB
$131.95
$3.953.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.33% | 6.13% | 2.87% | -2.55% | 0.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.33% | 6.13% | 2.87% | -2.55% | 0.36% |
| Cost of Revenue | 10.08% | 16.02% | -5.63% | -3.17% | -15.32% |
| Gross Profit | 6.62% | 3.39% | 5.84% | -2.33% | 5.35% |
| SG&A Expenses | 5.63% | -0.64% | 11.61% | -23.36% | 2.57% |
| Depreciation & Amortization | 46.61% | 42.78% | 18.80% | 113.96% | 64.27% |
| Other Operating Expenses | 20.19% | -11.43% | 5.16% | 37.23% | 9.67% |
| Total Operating Expenses | 4.50% | 5.49% | 0.08% | -13.51% | -9.18% |
| Operating Income | 13.11% | 7.83% | 14.49% | 89.06% | 27.82% |
| Income Before Tax | 6.48% | -33.05% | -0.03% | 419.41% | -1.33% |
| Income Tax Expenses | -5.13% | -0.98% | -41.92% | 185.73% | 0.26% |
| Earnings from Continuing Operations | 8.77% | -38.87% | 7.15% | 668.81% | -1.63% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.77% | -38.87% | 6.81% | 670.48% | -1.35% |
| EBIT | 13.11% | 7.83% | 14.49% | 89.06% | 27.82% |
| EBITDA | 14.61% | 10.92% | 18.41% | 75.52% | 29.00% |
| EPS Basic | 8.11% | -39.24% | 6.22% | 666.96% | -1.96% |
| Normalized Basic EPS | 13.42% | 13.32% | 36.74% | 57.81% | 16.08% |
| EPS Diluted | 8.25% | -39.26% | 6.30% | 665.60% | -1.72% |
| Normalized Diluted EPS | 13.50% | 13.47% | 37.13% | 57.37% | 16.48% |
| Average Basic Shares Outstanding | 0.62% | 0.62% | 0.55% | 0.62% | 0.62% |
| Average Diluted Shares Outstanding | 0.55% | 0.48% | 0.27% | 0.90% | 0.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |